Blockade of peroxynitrite-induced neural stem cell death in the acutely injured spinal cord by drug-releasing polymer (Stem Cells (2009) 27, (1212) DOI: 10.1002/stem.26);Blockade of peroxynitrite-induced neural stem cell death in the acutely injured spinal cord by drug-releasing polymer

Stem Cells

Volumn 27, Issue 5, 2009, Pages 1212-1222

  Yu, Dou ^a,b   Neeley, William L ^c   Pritchard, Christopher D ^a,c   Slotkin, Jonathan R ^a,c   Woodard, Eric J ^c   Langer, Robert ^c,d   Teng, Yang D ^a,b,e  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c NEW ENGLAND BAPTIST HOSPITAL   (United States)

^d MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

^e and Red Sox Foundation and Massachusetts General Hospital Home Base Program   (United States)

Author keywords

Neural stem cell; Neuroinflammation; Nitric oxide; Peroxynitrite; PLGA scaffold; Spinal cord injury

Indexed keywords

CASPASE; CYTOCHROME C; GLUTAMIC ACID; INDUCIBLE NITRIC OXIDE SYNTHASE; LINSIDOMINE; MANGANESE DERIVATIVE; MANGANESE TETRAKIS(4 BENZOIC ACID)PORPHYRIN; MITOGEN ACTIVATED PROTEIN KINASE P38; PEROXYNITRITE; POLYGLACTIN; SCAVENGER; SPERMINE; UNCLASSIFIED DRUG; URIC ACID;

ACUTE DISEASE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL DEATH; CELL SURVIVAL; CONTROLLED STUDY; DRUG RELEASE; ENZYME ACTIVATION; FEMALE; FETUS; GRAFT SURVIVAL; HOST CELL; HUMAN; HUMAN CELL; IN VITRO STUDY; NERVOUS SYSTEM INJURY; NEURAL STEM CELL; NEURAL STEM CELL TRANSPLANTATION; NEUROPROTECTION; NITRATION; NONHUMAN; PROTEIN EXPRESSION; PROTEIN SECRETION; RAT; SPINAL CORD INJURY; TISSUE ENGINEERING;

RATTUS;

EID: 66149190690     PISSN: 10665099     EISSN: None     Source Type: Journal    
DOI: 10.1002/stem.266     Document Type: Erratum

References (72)

1. Donnelly DJ, Popovich PG. Inflammation and its role in neuroprotection, axonal regeneration and functional recovery after spinal cord injury. Exp Neurol 2008;209:378-388.
2. Bramlett HM, Dietrich WD. Progressive damage after brain and spinal cord injury: Pathomechanisms and treatment strategies. Prog Brain Res 2007;161:125-141. (Pubitemid 47017402)
3. Crutcher KA, Gendelman HE, Kipnis J et al. Debate: "Is increasing neuroinflammation beneficial for neural repair?". J Neuroimmune Pharmacol 2006;1:195-211.
4. Zhou L, Wu W. Antisense oligos to neuronal nitric oxide synthase aggravate motoneuron death induced by spinal root avulsion in adult rat. Exp Neurol 2006;197:84-92. (Pubitemid 41817223)
5. Xu M, Ng YK, Leong SK. Neuroprotective and neurodestructive functions of nitric oxide after spinal cord hemisection. Exp Neurol 2000;161:472-480. (Pubitemid 30137007)
6. Nakahara S, Yone K, Setoguchi T et al. Changes in nitric oxide and expression of nitric oxide synthase in spinal cord after acute traumatic injury in rats. J Neurotrauma 2002;19:1467-1474. (Pubitemid 35403675)
7. Chatzipanteli K, Garcia R, Marcillo AE et al. Temporal and segmental distribution of constitutive and inducible nitric oxide synthases after traumatic spinal cord injury: Effect of aminoguanidine treatment. J Neurotrauma 2002;19:639-651. (Pubitemid 34587306)
8. Díaz-Ruiz A, Ibarra A, Pérez-Severiano F et al. Constitutive and inducible nitric oxide synthase activities after spinal cord contusion in rats. Neurosci Lett 2002;319:129-132. (Pubitemid 34143189)
9. Lladó J, Haenggeli C, Maragakis NJ et al. Neural stem cells protect against glutamate-induced excitotoxicity and promote survival of injured motor neurons through the secretion of neurotrophic factors. Mol Cell Neurosci 2004;27:322-331. (Pubitemid 39433844)
10. Hsieh WY, Hsieh YL, Liu DD et al. Neural progenitor cells resist excitatory amino acid-induced neurotoxicity. J Neurosci Res 2003;71:272-278. (Pubitemid 36055472)
11. Teng YD, Wrathall JR. Local blockade of sodium channels by tetrodotoxin ameliorates tissue loss and long-term functional deficits resulting from experimental spinal cord injury. J Neurosci 1997;17:4359-4366. (Pubitemid 27220626)
12. Radi R, Cassina A, Hodara R. Nitric oxide and peroxynitrite interactions with mitochondria. Biol Chem 2002;383:401-409. (Pubitemid 34506280)
13. Brunori M, Giuffrè A, Forte E et al. Control of cytochrome c oxidase activity by nitric oxide. Biochim Biophys Acta 2004;1655:365-371. (Pubitemid 38526200)
14. Brüne B, von Knethen A, Sandau KB. Nitric oxide and its role in apoptosis. Eur J Pharmacol 1998;351:261-272. (Pubitemid 28321461)
15. Dedon PC, Tannenbaum SR. Reactive nitrogen species in the chemical biology of inflammation. Arch Biochem Biophys 2004;423:12-22. (Pubitemid 38202218)
16. Cheng A, Chan SL, Milhavet O et al. p38 MAP kinase mediates nitric oxide-induced apoptosis of neural progenitor cells. J Biol Chem 2001;276:43320-43327. (Pubitemid 37371021)
17. Kaji T, Kaieda I, Hisatsune T et al. 3-Morpholinosydnonimine hydrochloride induces p53-dependent apoptosis in murine primary neural cells: A critical role for p21(ras)-MAPK-p19(ARF) pathway. Nitric Oxide 2002;6:125-134.
18. Ghatan S, Larner S, Kinoshita Y et al. p38 MAP kinase mediates bax translocation in nitric oxide-induced apoptosis in neurons. J Cell Biol 2000;150:335-347. (Pubitemid 30491357)
19. Gibbs SM. Regulation of neuronal proliferation and differentiation by nitric oxide. Mol Neurobiol 2003;27:107-120. (Pubitemid 36724515)
20. Keynes RG, Garthwaite J. Nitric oxide and its role in ischaemic brain injury. Curr Mol Med 2004;4:179-191. (Pubitemid 38425913)
21. Deckel AW. Nitric oxide and nitric oxide synthase in Huntington's disease. J Neurosci Res 2001;64:99-107. (Pubitemid 32260180)
22. Thuret S, Moon LD, Gage FH. Therapeutic interventions after spinal cord injury. Nat Rev Neurosci 2006;7:628-643. (Pubitemid 44106745)
23. Goldman SA, Windrem MS. Cell replacement therapy in neurological disease. Philos Trans R Soc Lond B Biol Sci 2006;361:1463-1475. (Pubitemid 44450205)
24. Teng YD, Lavik EB, Qu X et al. Functional recovery following traumatic spinal cord injury mediated by a unique polymer scaffold seeded with neural stem cells. Proc Natl Acad Sci USA 2002;99:3024-3029. (Pubitemid 34240579)
25. Murray M, Fischer I. Transplantation and gene therapy: Combined approaches for repair of spinal cord injury. Neuroscientist 2001;7:28-41. (Pubitemid 32098821)
26. Raisman G, Li Y. Repair of neural pathways by olfactory ensheathing cells. Nat Rev Neurosci 2007;8:312-319. (Pubitemid 46452322)
27. Teng YD, Liao WL, Choi H et al. Physical activity-mediated functional recovery after spinal cord injury: Potential roles of neural stem cells. Regen Med 2006;1:763-776.
28. Karp JM, Langer R. Development and therapeutic applications of advanced biomaterials. Curr Opin Biotechnol 2007;18:454-459. (Pubitemid 350116590)
29. Redmond DE Jr., Bjugstad KB, Teng YD et al. Behavioral improvement in a primate Parkinson's model is associated with multiple homeostatic effects of human neural stem cells. Proc Natl Acad Sci USA 2007;104:12175-12180. (Pubitemid 47185649)
30. Teng YD, Choi H, Onario RC et al. Minocycline inhibits contusion-triggered mitochondrial cytochrome c release and mitigates functional deficits after spinal cord injury. Proc Natl Acad Sci USA 2004;101:3071-3076. (Pubitemid 38327736)
31. Grayson AC, Cima MJ, Langer R. Size and temperature effects on poly(lactic-co-glycolic acid) degradation and microreservoir device performance. Biomaterials 2005;26:2137-2145. (Pubitemid 39575357)
32. Harriman A, Porter G. Photochemistry of manganese porphyrins. J Chem Soc Faraday Trans 1979;275:1532-1542.
33. Kalckar HM. Differential spectrophotometry of punne compounds by means of specific enzymes. I. Determination of hydroxypurine compounds. J Biol Chem 1947;167:429-443.
34. Teng YD, Mocchetti I, Wrathall JR. Basic and acidic fibroblast growth factors protect spinal motor neurones in vivo after experimental spinal cord injury. Eur J Neurosci 1998;10:798-802. (Pubitemid 28325508)
35. Fonnum F. Glutamate: A neurotransmitter in mammalian brain. J Neurochem 1984;42:1-11.
36. Zhang Y, Wang H, Li J et al. Intracellular zinc release and ERK phosphorylation are required upstream of 12-lipoxygenase activation in peroxynitrite toxicity to mature rat oligodendrocytes. J Biol Chem 2006;281:9460-9470. (Pubitemid 43864663)
37. Ricci-Vitiani L, Pedini F, Mollinari C et al. Absence of caspase 8 and high expression of PED protect primitive neural cells from cell death. J Exp Med 2004;200:1257-1266. (Pubitemid 39552567)
38. Szabó C, Day BJ, Salzman AL. Evaluation of the relative contribution of nitric oxide and peroxynitrite to the suppression of mitochondrial respiration in immunostimulated macrophages using a manganese mesoporphyrin superoxide dismutase mimetic and peroxynitrite scavenger. FEBS Lett 1996;381:82-86. (Pubitemid 126352613)
39. Fischer I. Candidate cells for transplantation into the injured CNS. Prog Brain Res 2000;128:253-257. (Pubitemid 35461241)
40. Lu KT, Wang YW, Yang JT et al. Effect of interleukin-1 on traumatic brain injury-induced damage to hippocampal neurons. J Neurotrauma 2005;22:885-895. (Pubitemid 41153873)
41. Cai Z, Pang Y, Lin S et al. Differential roles of tumor necrosis factor-α and interleukin-1 β in lipopolysaccharide-induced brain injury in the neonatal rat. Brain Res 2003;975:37-47. (Pubitemid 36588550)
42. Shamash S, Reichert F, Rotshenker S. The cytokine network of Wallerian degeneration: Tumor necrosis factor-α, interleukin-1α, and interleukin-1β. J Neurosci 2002;22:3052-3060. (Pubitemid 35379194)
43. Hall ED, Springer JE. Neuroprotection and acute spinal cord injury: A reappraisal. Neurorx 2004;1:80-100.
44. Li S, Stys PK. Mechanisms of ionotropic glutamate receptor-mediated excitotoxicity in isolated spinal cord white matter. J Neurosci 2000;20:1190-1198. (Pubitemid 30220475)
45. Liu NK, Zhang YP, Titsworth WL et al. A novel role of phospholipase A2 in mediating spinal cord secondary injury. Ann Neurol 2006;59:606-619.
46. Kawano T, Anrather J, Zhou P et al. Prostaglandin E2 EP1 receptors: Downstream effectors of COX-2 neurotoxicity. Nat Med 2006;12:225-229. (Pubitemid 43214750)
47. Kwon KJ, Jung YS, Lee SH et al. Arachidonic acid induces neuronal death through lipoxygenase and cytochrome P450 rather than cyclooxygenase. J Neurosci Res 2005;81:73-84. (Pubitemid 41139112)
48. Manabe Y, Anrather J, Kawano T et al. Prostanoids, not reactive oxygen species, mediate COX-2-dependent neurotoxicity. Ann Neurol 2004;55:668-675. (Pubitemid 38544327)
49. Easton AS, Fraser PA. Arachidonic acid increases cerebral microvascular permeability by free radicals in single pial microvessels of the anaesthetized rat. J Physiol 1998;507:541-547. (Pubitemid 28135202)
50. Kulbatski I, Mothe AJ, Nomura H et al. Endogenous and exogenous CNS derived stem/progenitor cell approaches for neurotrauma. Curr Drug Targets 2005;6:111-126. (Pubitemid 40403011)
51. Iarikov DE, Kim BG, Dai HN et al. Delayed transplantation with exogenous neurotrophin administration enhances plasticity of corticofugal projections after spinal cord injury. J Neurotrauma 2007;24:690-702. (Pubitemid 46996028)
52. Yu D, Wilhelmsson U, Pekny M et al. A polymer scaffold mediated neural stem cell treatment for lower thoracic spinal cord injury in GFAP-/- Vimentin-/- mice. Soc Neurosci Abstract 2008;online.
53. Beattie MS. Inflammation and apoptosis: Linked therapeutic targets in spinal cord injury. Trends Mol Med 2004;10:580-583. (Pubitemid 39573147)
54. Conti A, Miscusi M, Cardali S et al. Nitric oxide in the injured spinal cord: Synthases cross-talk, oxidative stress and inflammation. Brain Res Rev 2007;54:205-218. (Pubitemid 46498169)
55. Dalkara T, Yoshida T, Irikura K et al. Dual role of nitric oxide in focal cerebral ischemia. Neuropharmacology 1994;33:1447-1452. (Pubitemid 24353740)
56. Iadecola C. Bright and dark sides of nitric oxide in ischemic brain injury. Trends Neurosci 1997;20:132-139. (Pubitemid 27086729)
57. Madhavan L, Ourednik V, Ourednik J. Neural stem/progenitor cells initiate the formation of cellular networks that provide neuroprotection by growth factor-modulated antioxidant expression. Stem Cells 2008;26:254-265.
58. Peterson DA, Lucidi-Phillipi CA, Murphy DP et al. Fibroblast growth factor-2 protects entorhinal layer II glutamatergic neurons from axotomy-induced death. J Neurosci 1996;16:886-898. (Pubitemid 26140844)
59. Patel M, Day BJ. Metalloporphyrin class of therapeutic catalytic antioxidants. Trends Pharmacol Sci 1999;20:359-364. (Pubitemid 29421616)
60. Hunt JA, Lee J, Groves JT. Amphiphilic peroxynitrite decomposition catalysts in liposomal assemblies. Chem Biol 1997;4:845-858. (Pubitemid 28000624)
61. Bao F, DeWitt DS, Prough DS et al. Peroxynitrite generated in the rat spinal cord induces oxidation and nitration of proteins: Reduction by Mn (III) tetrakis (4-benzoic acid) porphyrin. J Neurosci Res 2003;71:220-227. (Pubitemid 36055466)
62. Bao F, Liu D. Peroxynitrite generated in the rat spinal cord induces neuron death and neurological deficits. Neuroscience 2002;115:839-849. (Pubitemid 35336026)
63. Liu D, Bao F, Prough DS et al. Peroxynitrite generated at the level produced by spinal cord injury induces peroxidation of membrane phospholipids in normal rat cord: Reduction by a metalloporphyrin. J Neurotrauma 2005;22:1123-1133. (Pubitemid 41532549)
64. Hachmeister JE, Valluru L, Bao F et al. Mn (III) tetrakis (4-benzoic acid) porphyrin administered into the intrathecal space reduces oxidative damage and neuron death after spinal cord injury: A comparison with methylprednisolone. J Neurotrauma 2006;23:1766-1778. (Pubitemid 46034450)
65. Bjugstad KB, Teng YD, Redmond DE Jr et al. Human neural stem cells migrate along the nigrostriatal pathway in a primate model of Parkinson's disease. Exp Neurol 2008;211:362-369.
66. Coyle JT, Puttfarcken P. Oxidative stress, glutamate, and neurodegenerative disorders. Science 1993;262:689-695. (Pubitemid 23350687)
67. Dumuis A, Sebben M, Haynes L et al. NMDA receptors activate the arachidonic acid cascade system in striatal neurons. Nature 1998;336:68-70.
68. Lazarewicz JW, Wroblewski JT, Palmer ME et al. Activation of N-methyl-D-aspartate-sensitive glutamate receptors stimulates arachidonic acid release in primary cultures of cerebellar granule cells. Neuropharmacology 1988;27:765-769. (Pubitemid 18164009)
69. Dawson TM, Dawson VL, Snyder SH. A novel neuronal messenger molecule in brain: The free radical, nitric oxide. Ann Neurol 1992;32:297-311.
70. Palmer LA, Gaston B, Johns RA. Normoxic stabilization of hypoxia-inducible factor-1 expression and activity: Redox-dependent effect of nitrogen oxides. Mol Pharmacol 2000;58:1197-1203.
71. Hess DT, Matsumoto A, Kim SO et al. Protein S-nitrosylation: Purview and parameters. Nat Rev Mol Cell Biol 2005;6:150-166. (Pubitemid 40215810)
72. Feelisch M, Rassaf T, Mnaimneh S et al. Concomitant S-, N-, And heme-nitros(Yl)Ation in biological tissues and fluids: Implications for the fate of NO in vivo. FASEB J 2002;16:1775-1785.